Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 3 | 2010 | 193 | 0.450 |
Why?
|
| Fibroma | 2 | 2010 | 41 | 0.430 |
Why?
|
| Chondroma | 1 | 2009 | 2 | 0.350 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2009 | 2 | 0.350 |
Why?
|
| Thyroid Nodule | 1 | 2023 | 40 | 0.220 |
Why?
|
| Career Choice | 2 | 2019 | 116 | 0.200 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 162 | 0.190 |
Why?
|
| Faculty, Medical | 1 | 2019 | 100 | 0.160 |
Why?
|
| General Surgery | 1 | 2019 | 113 | 0.160 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2016 | 2 | 0.150 |
Why?
|
| Students, Medical | 1 | 2019 | 173 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2016 | 40 | 0.140 |
Why?
|
| Employment | 1 | 2016 | 95 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 117 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2016 | 374 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2019 | 501 | 0.120 |
Why?
|
| Radiography | 2 | 2010 | 524 | 0.100 |
Why?
|
| Bone Cysts | 1 | 2010 | 2 | 0.090 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2010 | 6 | 0.090 |
Why?
|
| Curettage | 1 | 2010 | 15 | 0.090 |
Why?
|
| Rhabdomyosarcoma | 1 | 2010 | 13 | 0.090 |
Why?
|
| Bone Transplantation | 1 | 2010 | 55 | 0.090 |
Why?
|
| Athletic Performance | 1 | 2010 | 46 | 0.090 |
Why?
|
| Sclerotherapy | 1 | 2009 | 47 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 65 | 0.080 |
Why?
|
| Hemangioma | 1 | 2009 | 83 | 0.080 |
Why?
|
| Adult | 6 | 2019 | 14182 | 0.080 |
Why?
|
| Pain | 1 | 2010 | 405 | 0.070 |
Why?
|
| Ethanol | 1 | 2009 | 322 | 0.070 |
Why?
|
| Microchemistry | 1 | 2005 | 6 | 0.070 |
Why?
|
| Electrophoresis, Capillary | 1 | 2005 | 16 | 0.070 |
Why?
|
| Creatinine | 1 | 2005 | 169 | 0.060 |
Why?
|
| Female | 6 | 2023 | 28418 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1056 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2023 | 256 | 0.050 |
Why?
|
| Humans | 8 | 2023 | 54246 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6432 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2010 | 246 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 579 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1679 | 0.040 |
Why?
|
| Physician Executives | 1 | 2016 | 17 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 765 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 3212 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 90 | 0.030 |
Why?
|
| Young Adult | 3 | 2010 | 4308 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2016 | 194 | 0.030 |
Why?
|
| Male | 4 | 2023 | 27312 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2010 | 5604 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 225 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 2387 | 0.030 |
Why?
|
| Philadelphia | 1 | 2010 | 14 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2010 | 8 | 0.020 |
Why?
|
| Vincristine | 1 | 2010 | 98 | 0.020 |
Why?
|
| Fracture Fixation, Internal | 1 | 2010 | 46 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2009 | 38 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2010 | 243 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 57 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2010 | 119 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 222 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 147 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 195 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2010 | 259 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 454 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 692 | 0.020 |
Why?
|
| Adolescent | 2 | 2010 | 6885 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 951 | 0.020 |
Why?
|
| Aged | 2 | 2010 | 10041 | 0.020 |
Why?
|
| Picrates | 1 | 2005 | 2 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 1543 | 0.020 |
Why?
|
| Linear Models | 1 | 2005 | 309 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 1361 | 0.020 |
Why?
|
| Middle Aged | 2 | 2010 | 13070 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 923 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 1604 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 3429 | 0.010 |
Why?
|
| Child | 1 | 2010 | 7337 | 0.010 |
Why?
|